In our study, CRBN(+) and DDB1(+) were associated with clinical features corresponding to the high burden of MM disease (a higher serum concentration of monoclonal protein or β2-microglobulin, as well as a haemoglobin concentration lower than 10 g/dL). Here, CRBN is linked to Miyoshi myopathy.